OTTAWA, Sept. 13, 2018 /CNW Telbec/ - LiveWell Canada Inc. ("LiveWell" or the "Company"), (TSXV: LVWL), is pleased to announce the completion of the initial phase of the Artiva facility in Ottawa for licensing. In cooperation with its partners Canopy Growth and Canopy Rivers, the Company has prepared its Confirmation of Readiness ("COR") package for submission to Health Canada to demonstrate its compliance with the Access to Cannabis for Medical Purposes Regulation (ACMPR) security requirements, for the purposes of obtaining a production license.
Upon receipt of its production license, the Company plans to immediately begin the next phase of expansion at the site. Subject to Health Canada and other standard regulatory approvals, the Company anticipates being ready to begin production once the production license has been granted.
The Artiva facility is strategically located in the nations capital in Ottawa, Ontario. The property sits on 100 acres of land with 540,000 square feet of existing greenhouses and 200,000 square feet of hot houses.
About LiveWell Canada
LiveWell Canada Inc. (TSXV: LVWL) is an innovative Canadian company planning to become a leader in a new approach to health and wellness by conducting advanced studies on cannabidiol (CBD) and other cannabinoids in its world-class Research and Innovation Centre located in Litchfield, Québec. The company's mission also includes developing and distributing prescription and consumer health products. With more than 1.5 million square feet of greenhouses under construction located in Ontario and Québec, the company is supported by renowned academic and business partners such as Canopy Growth (TSX: WEED) (NYSE: CGC) and Canopy Rivers. For more information, visit livewellcorp.com.
Cautionary Note Regarding Forward-Looking Statements
This release includes forward-looking statements about the Company and its business. Often, but not always, forward-looking statements can be identified by the use of words such as "plan", "continue", "expect", "schedule", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements (including negative variations) that certain events or conditions "may" or "will" occur. Such statements are based on the current expectations of management. The forward-looking events and circumstances discussed in this release may not occur by certain specified dates or at all and could differ materially as a result of unknown and known risk factors and uncertainties affecting the Company, including risks regarding the cannabis and hemp industry, economic factors, the equity markets and risks associated with growth and competition. The Company cautions that this foregoing list of material factors is not exhaustive, and readers are encouraged to read all Risk Factors disclosed in the Company's Filing Statement dated May 29, 2018.
The forward-looking information contained in this press release represents expectations of the Company as of the date of this press release and accordingly, is subject to change after such date. Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date. While the Company may elect to, it does not undertake to update this information at any particular time except as required in accordance with applicable securities laws.
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
For more information, visit livewellcorp.com.
SOURCE LiveWell Canada Inc.
For further information: Media, Stephane Prud'homme, 514-756-9044, [email protected]; Sonya Lord, 866-308-1518, [email protected]; Investors, Nicole Marchand, 416-428-3533, [email protected]; Company, David Rendimonti, President; Steven Archambault, Chief Financial Officer